Journals / Turkish Journal of Chemistry / 2020 / Cilt: 44 - Sayı: 6

Evaluation of carbonic anhydrase and paraoxonase inhibition activities and molecular docking studies of highly water-soluble sulfonated phthalocyanines

Pages
1565–1573
Publication Date
2020-12-16
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Docking studies were carried out to examine the interactions between hCA I, hCA II, and PON1 inhibitors and metal complexes at a molecular level and to predict binding energies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The investigation of carbonic anhydrase and paraoxonase enzyme inhibition properties of water-soluble zinc and gallium phthalocyanine complexes (1 and 2) are reported for the first time.
📊
Key Findings & Data:According to biological activity results, both complexes inhibited hCA I, hCA II, and PON1.
💡
Conclusion & Impact:Docking studies were carried out to examine the interactions between hCA I, hCA II, and PON1 inhibitors and metal complexes at a molecular level and to predict binding energies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Phthalocyanine · sulfonated · water-soluble

Abstract

The investigation of carbonic anhydrase and paraoxonase enzyme inhibition properties of water-soluble zinc and gallium phthalocyanine complexes (1 and 2) are reported for the first time. The binding of p-sulfonylphenoxy moieties to the phthalocyanine structure favors excellent solubilities in water, as well as providing an inhibition effect on carbonic anhydrase (CA) I and II isoenzymes and paraoxonase (PON I) enzyme. According to biological activity results, both complexes inhibited hCA I, hCA II, and PON1. Whereas 1 and 2 showed moderate hCA I and hCA II (off-target cytosolic isoforms) inhibitory activity (K-i values of 26.09 mu M and 43.11 mu M for hCA I and 30.95 mu M and 33.19 mu M for hCA II, respectively), they exhibited strong PON1 (associated with high-density lipoprotein [HDL]) inhibitory activity (K-i values of 0.37 mu M and 0.27 mu M, respectively). The inhibition kinetics were analyzed by Lineweaver-Burk double reciprocal plots. It revealed that 1 and 2 were noncompetitive inhibitors against PON1, hCA I, and hCA II. These complexes can be snore advantageous than other synthetic CA and PON inhibitors due to their water solubility. Docking studies were carried out to examine the interactions between hCA I, hCA II, and PON1 inhibitors and metal complexes at a molecular level and to predict binding energies.

🔖

Cite This Article

GUZEL, E., SONMEZ, F., ERKAN, S., CİKRİKCİ, K., ERGUN, A., GENCER, N., ARSLAN, O., KOCAK, M. B. (2020). Evaluation of carbonic anhydrase and paraoxonase inhibition activities and molecular docking studies of highly water-soluble sulfonated phthalocyanines. Turkish Journal of Chemistry, Cilt: 44 - Sayı: 6, 1565–1573. https://ajindex.com/articles/204670

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Arslan T, 2019, BIOORG CHEM, V90, DOI 10.1016/j.bioorg.2019.103100 Arslan T, 2018, RSC ADV, V8, P10172, DOI 10.1039/c7ra13674a Atahan A, 2018,
  2. CHEMISTRYSELECT, V3, P529, DOI 10.1002/slct.201702562 Bozdag M, 2015, J ENZYM INHIB MED CH, V30, P240, DOI 10.3109/14756366.2014.912216 Chen X, 2020, J OCEAN U CHINA, V19, P209, DOI 10.1007/s11802-020-4174-1 Chino Y, 2017, J PORPHYR PHTHALOCYA, V21, P159, DOI 10.1142/S1088424617500389 Cimen Y, 2014, SENSOR ACTUAT B-CHEM, V202, P1137, DOI 10.1016/j.snb.2014.06.066 Congiu C, 2014, BIOORG MED CHEM LETT, V24, P1776, DOI 10.1016/j.bmcl.2014.02.030 D'Ambrosio K, 2012, J MED CHEM, V55, P6776, DOI 10.1021/jm300818k Dumoulin F, 2010, COORDIN CHEM REV, V254, P2792, DOI 10.1016/j.ccr.2010.05.002 Erdemir P, 2019, BIOORG CHEM, V91, DOI 10.1016/j.bioorg.2019.103134 Feofanov A, 2002, PHOTOCHEM PHOTOBIOL, V75, P527, DOI 10.1562/0031-8655(2002)075 2.0.CO;2 Gokce B, 2019, J BIOCHEM MOL TOXIC, V33, DOI 10.1002/jbt.22407 Gunsel A, 2020, J MOL STRUCT, V1214, DOI 10.1016/j.molstruc.2020.128210 Guzel E, 2020, SYNTHETIC MET, V262, DOI 10.1016/j.synthmet.2020.116331 Guzel E, 2019, J ELECTROCHEM SOC, V166, pH438, DOI 10.1149/2.0511910jes Guzel E, 2019, RSC ADV, V9, P10854, DOI 10.1039/c8ra10665g Guzel E, 2017, J COORD CHEM, V70, P2659, DOI 10.1080/00958972.2017.1366471 Guzel E, 2017, INORG CHIM ACTA, V467, P169, DOI 10.1016/j.ica.2017.07.058 Guzel E, 2017, SUPRAMOL CHEM, V29, P536, DOI 10.1080/10610278.2017.1288232 Guzel E, 2015, SYNTHETIC MET, V199, P372, DOI 10.1016/j.synthmet.2014.11.032 Guzel E, 2013, DYES PIGMENTS, V97, P238, DOI 10.1016/j.dyepig.2012.12.027 Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767 Ivanova J, 2015, CHEM COMMUN, V51, P7108, DOI 10.1039/c5cc01854d Karatas MO, 2019, APPL ORGANOMET CHEM, V33, DOI 10.1002/aoc.5130 Karatas MO, 2016, BIOORGAN MED CHEM, V24, P1392, DOI 10.1016/j.bmc.2016.02.012 Karlik O, 2019, ARCH PHARM, V352, DOI 10.1002/ardp.201800325 Korkut SE, 2017, J PORPHYR PHTHALOCYA, V21, P16, DOI 10.1142/S1088424616501261 Kurt BZ, 2016, RUSS J BIOORG CHEM+, V42, P506, DOI 10.1134/S1068162016050046 Kurt BZ, 2019, EUR J MED CHEM, V183, DOI 10.1016/j.ejmech.2019.111702 Kurt BZ, 2019, BIOORG CHEM, V87, P838, DOI 10.1016/j.bioorg.2019.03.003 Kurt BZ, 2017, J ENZYM INHIB MED CH, V32, P1042, DOI 10.1080/14756366.2017.1354857 Kurt BZ, 2016, J ENZYM INHIB MED CH, V31, P991, DOI 10.3109/14756366.2015.1077823 Kurt O, 2015, NEW J CHEM, V39, P5767, DOI 10.1039/c5nj00933b Lineweaver H, 1934, J AM CHEM SOC,